Table 4:
Comparison of cardiac structure and function in SLE patients with CMD compared to SLE patients without on cMRI.
| CMD (N=5) | No CMD (N=8) | Total (N=13) | p value | |
|---|---|---|---|---|
| LVEDVi(mL/m2) | 0.0068 | |||
| Median | 60.3 | 76.8 | 70.7 | |
| Q1, Q3 | 56.4, 65.2 | 70.8, 84.8 | 65.2, 80.7 | |
| LVESVi(mL/m2) | ns | |||
| Median | 23.3 | 29.3 | 27.4 | |
| Q1, Q3 | 22.0, 27.1 | 26.4, 42.6 | 23.3, 34.1 | |
| LVMi(g/m2) | 0.0233 | |||
| Median | 35.7 | 53.4 | 45.6 | |
| Q1, Q3 | 35.3, 45.1 | 46.7, 58.1 | 42.8, 55.6 | |
| LVSVi(mL/m2) | 0.0481 | |||
| Median | 36.3 | 44.6 | 42.4 | |
| Q1, Q3 | 33.0, 38.2 | 41.5, 52.8 | 36.3, 45.5 | |
| LVEF(%) | ns | |||
| Median | 58.6 | 57.2 | 58.6 | |
| Q1, Q3 | 58.5, 63.6 | 53.6, 63.9 | 53.7, 63.6 | |
| LVSV(mL) | 0.0451 | |||
| Median | 65.9 | 86.9 | 67.6 | |
| Q1, Q3 | 51.9, 67.2 | 74.8, 95.2 | 64.3, 87.6 | |
| Radial Strain(%) | ns | |||
| Median | 27 | 27.7 | 27.5 | |
| Q1, Q3 | 26.5, 35.7 | 27.0, 36.0 | 26.5, 36.0 | |
| Longitudinal Strain(%) | ns | |||
| Median | −17.6 | −19.1 | −18.8 | |
| Q1, Q3 | −19.3, −16.8 | −20.0, −17.9 | −19.5, −16.8 | |
| Circumferential Strain(%) | ns | |||
| Median | −17.2 | −17.2 | −17.2 | |
| Q1, Q3 | −20.3, −16.9 | −20.4, −17.0 | −20.4, −16.9 | |
| T1 (ms) | ns | |||
| Median | 1258 | 1261 | 1261 | |
| Q1, Q3 | 1,25,01,278 | 1252.5, 1265.5 | 1245, 1272 | |
| T2(ms) | ns | |||
| Median | 44 | 42.5 | 43 | |
| Q1, Q3 | 40, 45 | 40.8, 44.5 | 40, 45 | |
| ECV(%) | ns | |||
| Median | 29 | 28 | 28.5 | |
| Q1, Q3 | 26, 29 | 27.5, 29.5 | 27, 29.3 |
Wilcoxon rank-sum test was used to determine potential differences in cardiac function between patients with CMD (N=5) versus those without CMD (N=8). LVEDVi: left ventricular end-diastolic volume index; LVESVi: left ventricular end-systolic volume index; LVMi: left ventricular mass index, LVSV: left ventricular systolic volume; LVSVi: LVSV index; LVEF: left ventricular ejection fraction; ECV: extracellular volume.